関連する実験動画
Updated: Apr 13, 2026

08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
3.4K
Moringa oleifera の潜在的高血圧抑制効果に関する洞察調査
Wasim S M Qadi1, Nini Tasnim Fadzel1, Ahmed Mediani1
1Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia, UKM Bangi, Selangor 43600, Malaysia.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 29, 2025
まとめ
血管機能を改善し,血圧を下げることで高血圧の管理の可能性を示しています. 自然療法としての臨床的効果と安全性を確認するには,さらなる研究が必要である.
科学分野:
- 心血管薬学
- 自然製品化学
- 栄養学
背景:
- 高血圧は世界の主要な健康問題であり 心血管疾患の罹患率と死亡率を高めています
- 天然製品が高血圧の管理にますます研究され,モリンガオレイフェラは有望な結果を示しています.
- モリンガ・オリーフェラは 抗高血圧効果を持つ生物活性化合物を含んでいます
研究 の 目的:
- モリンガ・オリーフェラとその成分の抗高血圧性を見直す
- 血圧を下げるモリンガオライフェラのメカニズムを探る
- モリンガオレイフェラの治療効果を高めるための高度な成分の役割を評価する.
主な方法:
- 科学データベースの文献レビュー (ScienceDirect,Google Scholar,PubMedなど) ) でした.
- Moringa oleiferaの生物活性成分とその薬理学的作用に関する研究の分析
- モリンガ化合物の投与を改善するためのナノ製剤技術に関する研究の検討.
主要な成果:
- モリンガオレイフェラの成分は血管拡張性,抗酸化性,およびACE抑制性を持っています.
- メカニズムには,酸化窒素の合成,ACE抑制,抗酸化作用,尿路の強化が含まれています.
- カリウム,マグネシウム,カルシウムなどの栄養成分は 心血管の健康を支えています
- ナノ製剤は,モリンガ化合物の安定性,生物活性,制御された放出を改善します.
結論:
- Moringa oleiferaは高血圧の補助療法として有意な治療力を示しています.
- バイオアクティブ化合物と栄養成分が抗高血圧効果に寄与する.
- 効果と安全性を検証するためにさらなる臨床試験が必要である.
関連する概念動画
Hypertension and Regulation of Blood Pressure
4.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Hypertension I: Introduction
1.3K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.3K
Hypertension II: Pathophysiology
1.6K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies
763
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
763
Hypertension IV: Drug Therapy and Lifestyle Modifications
901
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
901

